Omidubicel-Onlv: The First Commercially Available Alternative Allogeneic Hematopoietic Stem Cell Transplantation Donor Source.
BACKGROUND: Although allogeneic hematopoietic stem cell transplantation (alloHSCT) can be a lifesaving therapy for patients with hematologic malignancies, only 30% of patients in need of transplantation will have a human leukocyte antigen matched related donor available. OBJECTIVES: This article int...
| Publicado en: | Clinical Journal of Oncology Nursing Vol. 29; no. 3; pp. 230 - 237 |
|---|---|
| Autores principales: | , |
| Formato: | glossary tables/charts Journal Article |
| Publicado: |
Oncology Nursing Society
Jun2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |